74 related articles for article (PubMed ID: 34526323)
21. Ferroptosis-related lncRNA pairs to predict the clinical outcome and molecular characteristics of pancreatic ductal adenocarcinoma.
Tang R; Wu Z; Rong Z; Xu J; Wang W; Zhang B; Yu X; Shi S
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34553745
[TBL] [Abstract][Full Text] [Related]
22. Adverse Events as a Potential Clinical Marker of Antitumor Efficacy in Ovarian Cancer Patients Treated With Poly ADP-Ribose Polymerase Inhibitor.
Ni J; Cheng X; Zhou R; Zhao Q; Xu X; Guo W; Gu H; Chen C; Chen X
Front Oncol; 2021; 11():724620. PubMed ID: 34552876
[TBL] [Abstract][Full Text] [Related]
23. Targeting the IGF-Axis Potentiates Immunotherapy for Pancreatic Ductal Adenocarcinoma Liver Metastases by Altering the Immunosuppressive Microenvironment.
Hashimoto M; Konda JD; Perrino S; Celia Fernandez M; Lowy AM; Brodt P
Mol Cancer Ther; 2021 Dec; 20(12):2469-2482. PubMed ID: 34552012
[TBL] [Abstract][Full Text] [Related]
24.
Maddipati R; Norgard RJ; Baslan T; Rathi KS; Zhang A; Saeid A; Higashihara T; Wu F; Kumar A; Annamalai V; Bhattacharya S; Raman P; Adkisson CA; Pitarresi JR; Wengyn MD; Yamazoe T; Li J; Balli D; LaRiviere MJ; Ngo TC; Folkert IW; Millstein ID; Bermeo J; Carpenter EL; McAuliffe JC; Oktay MH; Brekken RA; Lowe SW; Iacobuzio-Donahue CA; Notta F; Stanger BZ
Cancer Discov; 2022 Feb; 12(2):542-561. PubMed ID: 34551968
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer.
Zou Q; Wang X; Ren D; Hu B; Tang G; Zhang Y; Huang M; Pai RK; Buchanan DD; Win AK; Newcomb PA; Grady WM; Yu H; Luo Y
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34548385
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer-Associated Fibroblasts.
Helms EJ; Berry MW; Chaw RC; DuFort CC; Sun D; Onate MK; Oon C; Bhattacharyya S; Sanford-Crane H; Horton W; Finan JM; Sattler A; Makar R; Dawson DW; Xia Z; Hingorani SR; Sherman MH
Cancer Discov; 2022 Feb; 12(2):484-501. PubMed ID: 34548310
[TBL] [Abstract][Full Text] [Related]
27. miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis.
Ge W; Goga A; He Y; Silva PN; Hirt CK; Herrmanns K; Guccini I; Godbersen S; Schwank G; Stoffel M
Gastroenterology; 2022 Jan; 162(1):269-284. PubMed ID: 34547282
[TBL] [Abstract][Full Text] [Related]
28. Interplay of Tumor Microenvironment Factors and Cancer Stem Cell Enrichment in Pancreatic Ductal Adenocarcinoma.
Zhang Y; Yang J; Bronze MS; Houchen CW; Li M
Gastroenterology; 2021 Dec; 161(6):1800-1802. PubMed ID: 34536452
[No Abstract] [Full Text] [Related]
29. MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I.
Brägelmann J; Lorenz C; Borchmann S; Nishii K; Wegner J; Meder L; Ostendorp J; Ast DF; Heimsoeth A; Nakasuka T; Hirabae A; Okawa S; Dammert MA; Plenker D; Klein S; Lohneis P; Gu J; Godfrey LK; Forster J; Trajkovic-Arsic M; Zillinger T; Haarmann M; Quaas A; Lennartz S; Schmiel M; D'Rozario J; Thomas ES; Li H; Schmitt CA; George J; Thomas RK; von Karstedt S; Hartmann G; Büttner R; Ullrich RT; Siveke JT; Ohashi K; Schlee M; Sos ML
Nat Commun; 2021 Sep; 12(1):5505. PubMed ID: 34535668
[TBL] [Abstract][Full Text] [Related]
30. Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence.
Dreyer SB; Upstill-Goddard R; Legrini A; Biankin AV; ; Jamieson NB; Chang DK; ; Jamieson NB; Chang DK
Gastroenterology; 2022 Jan; 162(1):320-324.e4. PubMed ID: 34534536
[No Abstract] [Full Text] [Related]
31. Proteogenomic characterization of pancreatic ductal adenocarcinoma.
Cao L; Huang C; Cui Zhou D; Hu Y; Lih TM; Savage SR; Krug K; Clark DJ; Schnaubelt M; Chen L; da Veiga Leprevost F; Eguez RV; Yang W; Pan J; Wen B; Dou Y; Jiang W; Liao Y; Shi Z; Terekhanova NV; Cao S; Lu RJ; Li Y; Liu R; Zhu H; Ronning P; Wu Y; Wyczalkowski MA; Easwaran H; Danilova L; Mer AS; Yoo S; Wang JM; Liu W; Haibe-Kains B; Thiagarajan M; Jewell SD; Hostetter G; Newton CJ; Li QK; Roehrl MH; Fenyö D; Wang P; Nesvizhskii AI; Mani DR; Omenn GS; Boja ES; Mesri M; Robles AI; Rodriguez H; Bathe OF; Chan DW; Hruban RH; Ding L; Zhang B; Zhang H;
Cell; 2021 Sep; 184(19):5031-5052.e26. PubMed ID: 34534465
[TBL] [Abstract][Full Text] [Related]
32. Antigen dominance hierarchies shape TCF1
Burger ML; Cruz AM; Crossland GE; Gaglia G; Ritch CC; Blatt SE; Bhutkar A; Canner D; Kienka T; Tavana SZ; Barandiaran AL; Garmilla A; Schenkel JM; Hillman M; de Los Rios Kobara I; Li A; Jaeger AM; Hwang WL; Westcott PMK; Manos MP; Holovatska MM; Hodi FS; Regev A; Santagata S; Jacks T
Cell; 2021 Sep; 184(19):4996-5014.e26. PubMed ID: 34534464
[TBL] [Abstract][Full Text] [Related]
33. Trastuzumab Deruxtecan in
Li BT; Smit EF; Goto Y; Nakagawa K; Udagawa H; Mazières J; Nagasaka M; Bazhenova L; Saltos AN; Felip E; Pacheco JM; Pérol M; Paz-Ares L; Saxena K; Shiga R; Cheng Y; Acharyya S; Vitazka P; Shahidi J; Planchard D; Jänne PA;
N Engl J Med; 2022 Jan; 386(3):241-251. PubMed ID: 34534430
[TBL] [Abstract][Full Text] [Related]
34. TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response.
Zeng Z; Wong CJ; Yang L; Ouardaoui N; Li D; Zhang W; Gu S; Zhang Y; Liu Y; Wang X; Fu J; Zhou L; Zhang B; Kim S; Yates KB; Brown M; Freeman GJ; Uppaluri R; Manguso R; Liu XS
Nucleic Acids Res; 2022 Jan; 50(D1):D1391-D1397. PubMed ID: 34534350
[TBL] [Abstract][Full Text] [Related]
35. Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates.
Liao JB; Gwin WR; Urban RR; Hitchcock-Bernhardt KM; Coveler AL; Higgins DM; Childs JS; Shakalia HN; Swensen RE; Stanton SE; Tinker AV; Wahl TA; Ancheta RG; McGonigle KF; Dai JY; Disis ML; Goff BA
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531249
[TBL] [Abstract][Full Text] [Related]
36. Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis.
Del Poggetto E; Ho IL; Balestrieri C; Yen EY; Zhang S; Citron F; Shah R; Corti D; Diaferia GR; Li CY; Loponte S; Carbone F; Hayakawa Y; Valenti G; Jiang S; Sapio L; Jiang H; Dey P; Gao S; Deem AK; Rose-John S; Yao W; Ying H; Rhim AD; Genovese G; Heffernan TP; Maitra A; Wang TC; Wang L; Draetta GF; Carugo A; Natoli G; Viale A
Science; 2021 Sep; 373(6561):eabj0486. PubMed ID: 34529467
[TBL] [Abstract][Full Text] [Related]
37. Stromal infiltrating mast cells identify immunoevasive subtype high-grade serous ovarian cancer with poor prognosis and inferior immunotherapeutic response.
Cao K; Zhang G; Zhang X; Yang M; Wang Y; He M; Lu J; Liu H
Oncoimmunology; 2021; 10(1):1969075. PubMed ID: 34527431
[TBL] [Abstract][Full Text] [Related]
38. Multiomic Analysis Reveals Comprehensive Tumor Heterogeneity and Distinct Immune Subtypes in Multifocal Intrahepatic Cholangiocarcinoma.
Chen S; Xie Y; Cai Y; Hu H; He M; Liu L; Liao C; Wang Y; Wang J; Ren X; Zeng Q; Peng H; Shen S; Li S; Li D; Lai J; Peng B; Ren J; Kuang M; Peng S
Clin Cancer Res; 2022 May; 28(9):1896-1910. PubMed ID: 34526363
[TBL] [Abstract][Full Text] [Related]
39. The Mutation Portraits of Oncogenes and Tumor Supressor Genes in Predicting the Overall Survival in Pancreatic Cancer: A Bayesian Network Meta-Analysis.
Aryanti C; Uwuratuw JA; Labeda I; Raharjo W; Lusikooy RE; Rauf MA; Mappincara A; Sampetoding S; Kusuma MI; Syarifuddin E
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2895-2902. PubMed ID: 37642079
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy and Pancreatic Cancer: A Lost Challenge?
Laface C; Memeo R; Maselli FM; Santoro AN; Iaia ML; Ambrogio F; Laterza M; Cazzato G; Guarini C; De Santis P; Perrone M; Fedele P
Life (Basel); 2023 Jun; 13(7):. PubMed ID: 37511856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
